164 related articles for article (PubMed ID: 35044328)
1. Review of publications evaluating opioid use in patients with inflammatory rheumatic disease.
Anastasiou C; Yazdany J
Curr Opin Rheumatol; 2022 Mar; 34(2):95-102. PubMed ID: 35044328
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
[TBL] [Abstract][Full Text] [Related]
3. The clinical application of etanercept in Chinese patients with rheumatic diseases.
Chou CT
Mod Rheumatol; 2006; 16(4):206-13. PubMed ID: 16906369
[TBL] [Abstract][Full Text] [Related]
4. Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff.
Alves de Oliveira Junior H; Pereira da Veiga T; Acurcio FA; Almeida AM; Ribeiro Dos Santos JB; da Silva MRR; Kakehasi AM; Cherchiglia ML
Hosp Pract (1995); 2020 Oct; 48(4):213-222. PubMed ID: 32567403
[TBL] [Abstract][Full Text] [Related]
5. Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials.
Steiman AJ; Pope JE; Thiessen-Philbrook H; Li L; Barnabe C; Kalache F; Kung T; Bessette L; Flanagan C; Haraoui B; Hochman J; Leclercq S; Mosher D; Thorne C; Bykerk V
Rheumatol Int; 2013 May; 33(5):1105-20. PubMed ID: 23292213
[TBL] [Abstract][Full Text] [Related]
6. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
[TBL] [Abstract][Full Text] [Related]
7. [Rheumatic diseases in pregnancy].
Märker-Hermann E; Bauer H; Gromnica-Ihle E
Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
[TBL] [Abstract][Full Text] [Related]
8. Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study.
Chen SK; Feldman CH; Brill G; Lee YC; Desai RJ; Kim SC
BMJ Open; 2019 Jun; 9(6):e027495. PubMed ID: 31221884
[TBL] [Abstract][Full Text] [Related]
9. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
[TBL] [Abstract][Full Text] [Related]
10. Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs.
Accortt NA; Bonafede MM; Collier DH; Iles J; Curtis JR
Arthritis Rheumatol; 2016 Jan; 68(1):67-76. PubMed ID: 26359948
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
[TBL] [Abstract][Full Text] [Related]
12. Opioid use in rheumatoid arthritis: trends, efficacy, safety, and best practices.
Day AL; Curtis JR
Curr Opin Rheumatol; 2019 May; 31(3):264-270. PubMed ID: 30870218
[TBL] [Abstract][Full Text] [Related]
13. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Ribbens C; Martin y Porras M; Franchimont N; Kaiser MJ; Jaspar JM; Damas P; Houssiau FA; Malaise MG
Ann Rheum Dis; 2002 Feb; 61(2):161-6. PubMed ID: 11796404
[TBL] [Abstract][Full Text] [Related]
14. High frequency of long-term opioid use among patients with rheumatic and musculoskeletal diseases initiating opioids for the first time.
Huang YT; Jenkins DA; Peek N; Dixon WG; Jani M
Ann Rheum Dis; 2023 Aug; 82(8):1116-1117. PubMed ID: 37193609
[No Abstract] [Full Text] [Related]
15. Fibromyalgia interferes with disease activity and biological therapy response in inflammatory rheumatic diseases.
Coskun Benlidayi I
Rheumatol Int; 2020 Jun; 40(6):849-858. PubMed ID: 31900502
[TBL] [Abstract][Full Text] [Related]
16. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
Mok CC; Ho LY; Tse SM; Chan KL; To CH
Clin Rheumatol; 2023 Apr; 42(4):1019-1026. PubMed ID: 36385600
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis.
Di Minno MN; Iervolino S; Lupoli R; Russolillo A; Coppola A; Peluso R; Scarpa R; Di Minno G
Semin Thromb Hemost; 2012 Jul; 38(5):497-505. PubMed ID: 22399309
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Ogdie A; de Vlam K; McInnes IB; Mease PJ; Baer P; Lukic T; Gruben D; Kwok K; Wang C; Hsu MA; Maniccia A
RMD Open; 2020 Feb; 6(1):. PubMed ID: 32396519
[TBL] [Abstract][Full Text] [Related]
20. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).
Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012437. PubMed ID: 27855242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
